| 15471-6 |
Equine influenza virus A2 Ab |
Titr |
Ser |
Pt |
SemiQn |
HAI |
|
ACTIVE |
Equine influenza virus A2 Ab [Titer] in Serum by Hemagglutination inhibition |
|
MAJ |
DefinitionDescription |
|
|
titer |
1:10 |
|
|
|
|
|
MICRO |
|
15471-6 |
|
HAI |
|
|
Both |
|
|
|
0 |
EIV A2 Ab Titr Ser HAI |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIV; EIV A2; Equin; Equine influenza; FLUV; HEMAGGLUTINATION INHIBITION; HI; ID; Infectious Disease; InfectiousDisease; Influ; Kentucky disease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 15472-4 |
Equine influenza virus Ag |
PrThr |
Nose |
Pt |
Ord |
IA |
|
ACTIVE |
Equine influenza virus Ag [Presence] in Nose by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15472-4 |
|
IA |
|
|
Both |
|
|
|
0 |
EIV Ag Nose Ql IA |
|
|
|
|
|
Antigen; Antigens; EIA; EIV; ELFA; ELISA; Enzyme immunoassay; Equin; Equine influenza; FLUV; IAA; ID; Infectious Disease; InfectiousDisease; Influ; MEIA; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell; SUDS; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15473-2 |
Equine arteritis virus Ab.Neut |
Titr |
Ser |
Pt |
SemiQn |
Neut |
|
ACTIVE |
Equine arteritis virus neutralizing antibody [Titer] in Serum by Neutralization test |
|
MAJ |
DefinitionDescription |
|
|
titer |
Neg@1:4 |
|
|
|
|
|
MICRO |
|
15473-2 |
|
Neut |
|
|
Both |
|
|
|
0 |
EAV NAb Titr Ser Nt |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arterivirus; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); EAV; Equin; Equine viral arteritis; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Vet; Veterinary; Virus neutralization test; VNT |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; |
0 |
| 15474-0 |
Infectious bursal disease virus Ab |
PrThr |
Ser |
Pt |
Ord |
Immune diffusion |
|
ACTIVE |
Infectious bursal disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15474-0 |
|
Immune diffusion |
|
|
Both |
|
|
|
0 |
IBDV Ab Ser Ql ID |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dis; Diseases; Dz; Gumboro disease; IBDV; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious bursal disease; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15475-7 |
Infectious bursal disease virus Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Infectious bursal disease virus Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Titer group 2 |
|
|
|
|
|
MICRO |
|
15475-7 |
|
IA |
|
|
Both |
|
|
|
0 |
IBDV Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dis; Diseases; Dz; EIA; ELFA; ELISA; Enzyme immunoassay; Gumboro disease; IAA; IBDV; ID; Infectious bursal disease; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 15476-5 |
Leptospira interrogans serovar Bratislava Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira interrogans sv Bratislava Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
Neg@1:100 |
|
|
|
|
|
MICRO |
|
15476-5 |
|
Aggl |
|
|
Both |
|
|
|
0 |
L inter Brat Ab Titr Ser Aggl |
|
|
|
Y |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Brat; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 15477-3 |
Leptospira interrogans serovar Canicola Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira interrogans sv Canicola Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
1:100 |
|
|
|
|
|
MICRO |
|
15477-3 |
|
Aggl |
|
|
Both |
|
|
|
0 |
L inter Canic Ab Titr Ser Aggl |
|
|
|
Y |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Canic; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 15478-1 |
Leptospira interrogans serovar Grippotyphosa Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
1:200 |
|
|
|
|
|
MICRO |
|
15478-1 |
|
Aggl |
|
|
Both |
|
|
|
0 |
L inter Grip Ab Titr Ser Aggl |
|
|
|
Y |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Grip; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 15479-9 |
Leptospira interrogans serovar Hardjo Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira interrogans sv Hardjo Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
1:100 |
|
|
|
|
|
MICRO |
|
15479-9 |
|
Aggl |
|
|
Both |
|
|
|
0 |
L inter Hard Ab Titr Ser Aggl |
|
|
|
Y |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Hard; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 1548-7 |
Glucose^pre 0.5 g/kg glucose IV |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --pre 0.5 g/kg glucose IV |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1548-7 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose pre .5 g/kg Glc IV SerPl-mCnc |
|
|
|
Y |
|
Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre .5 g/kg Glc IV; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 15480-7 |
Leptospira interrogans serovar Icterohaemorrhagiae Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
1:200 |
|
|
|
|
|
MICRO |
|
15480-7 |
|
Aggl |
|
|
Both |
|
|
|
0 |
L inter Icter Ab Titr Ser Aggl |
|
|
|
Y |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Icter; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 15481-5 |
Leptospira interrogans serovar Pomona Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira interrogans sv Pomona Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
Neg@1:100 |
|
|
|
|
|
MICRO |
|
15481-5 |
|
Aggl |
|
|
Both |
|
|
|
0 |
L inter Pomon Ab Titr Ser Aggl |
|
|
|
Y |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Pomon; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 15482-3 |
Mycobacterium avium subspecies paratuberculosis Ab |
PrThr |
Ser |
Pt |
Ord |
Immune diffusion |
|
ACTIVE |
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15482-3 |
|
Immune diffusion |
|
|
Both |
|
|
|
0 |
M avium paraTB Ab Ser Ql ID |
|
|
|
|
|
ABS; Aby; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; Johnes disease; M avium; M avium paraTB; Microbiology; Myco; Mycobact; Mycobacterium paratuberculosis; Ordinal; Paratuberculosis; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; ssp; Tuberculosis; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15483-1 |
Mycobacterium avium subspecies paratuberculosis Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
2197 |
|
|
|
|
|
MICRO |
|
15483-1 |
|
IA |
|
|
Both |
|
|
|
0 |
M avium paraTB Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Johnes disease; M avium; M avium paraTB; MEIA; Microbiology; Myco; Mycobact; Mycobacterium paratuberculosis; Ordinal; Paratuberculosis; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; ssp; SUDS; Tuberculosis; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 15484-9 |
Mycoplasma gallisepticum Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl |
|
ACTIVE |
Mycoplasma gallisepticum Ab [Presence] in Serum by Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
15484-9 |
|
Aggl |
|
|
Both |
|
|
|
0 |
M gallisep Ab Ser Ql Aggl |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian mycoplasmosis; Chronic respiratory disease; ID; Infectious Disease; InfectiousDisease; M gallisep; M gallisepticum; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 15485-6 |
Mycoplasma gallisepticum Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Mycoplasma gallisepticum Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Titer group 1 |
|
|
|
|
|
MICRO |
|
15485-6 |
|
IA |
|
|
Both |
|
|
|
0 |
M gallisep Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian mycoplasmosis; Chronic respiratory disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; M gallisep; M gallisepticum; MEIA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 15486-4 |
Mycoplasma gallisepticum rRNA |
PrThr |
Nose/Trac |
Pt |
Ord |
Probe |
|
ACTIVE |
Mycoplasma gallisepticum rRNA [Presence] in Nose or Trachea by Probe |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15486-4 |
|
Probe |
|
|
Both |
|
|
|
0 |
M gallisep rRNA Nose/Trachea Ql Probe |
|
|
|
|
|
Avian mycoplasmosis; Chronic respiratory disease; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; M gallisep; M gallisepticum; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Nasal; Nos; Nose (nasal passage); Nose/Trachea; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Smell; Trachea; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15487-2 |
Mycoplasma meleagridis Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Mycoplasma meleagridis Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Titer group 1 |
|
|
|
|
|
MICRO |
|
15487-2 |
|
IA |
|
|
Both |
|
|
|
0 |
M meleagridis Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; M meleagridis; MEIA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 15488-0 |
Mycoplasma meleagridis Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl |
|
ACTIVE |
Mycoplasma meleagridis Ab [Presence] in Serum by Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
15488-0 |
|
Aggl |
|
|
Both |
|
|
|
0 |
M meleagridis Ab Ser Ql Aggl |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; M meleagridis; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 15489-8 |
Mycoplasma synoviae Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Mycoplasma synoviae Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Titer group 1 |
|
|
|
|
|
MICRO |
|
15489-8 |
|
IA |
|
|
Both |
|
|
|
0 |
M synoviae Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; M synoviae; MEIA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 1549-5 |
Glucose^pre 100 g glucose PO |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --pre 100 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL.ROUTINE |
|
1549-5 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose pre 100 g Glc PO SerPl-mCnc |
|
|
|
Y |
|
Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre 100 g Glc PO; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
Changed Class from "CHAL" to "CHAL.ROUTINE" |
0 |
| 15490-6 |
Mycoplasma synoviae Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl |
|
ACTIVE |
Mycoplasma synoviae Ab [Presence] in Serum by Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
Neg |
|
|
|
|
|
MICRO |
|
15490-6 |
|
Aggl |
|
|
Both |
|
|
|
0 |
M synoviae Ab Ser Ql Aggl |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; M synoviae; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 15491-4 |
Mycoplasma synoviae rRNA |
PrThr |
Ser |
Pt |
Ord |
Probe |
|
ACTIVE |
Mycoplasma synoviae rRNA [Presence] in Serum by Probe |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15491-4 |
|
Probe |
|
|
Both |
|
|
|
0 |
M synoviae rRNA Ser Ql Probe |
|
|
|
|
|
DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; M synoviae; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15492-2 |
Neospora caninum Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Neospora caninum Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
15492-2 |
|
IA |
|
|
Both |
|
|
|
0 |
N caninum Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; N caninum; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 15493-0 |
Parainfluenza virus 3 Ab |
Titr |
Ser |
Pt |
SemiQn |
HAI |
|
ACTIVE |
Parainfluenza virus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
|
MAJ |
DefinitionDescription |
|
|
titer |
1:8 |
|
|
|
|
|
MICRO |
|
15493-0 |
|
HAI |
|
|
Both |
|
|
|
0 |
HPIV3 Ab Titr Ser HAI |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); HEMAGGLUTINATION INHIBITION; HI; HPIV; HPIV3; Human respirovirus 3; ID; III; Infectious Disease; InfectiousDisease; Microbiology; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PI3; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
